STAT

MAY 7, 2024

Drug development is essentially a long, expensive bet: 90% of drugs fail during clinical trials, goes one of the life science industry’s most oft-quoted statistics. But they cautioned that the pace of future successes will depend on whether the industry can streamline and rethink drug development.

Drug Development 209

Drug Development Vaccines 209

STAT

NOVEMBER 1, 2023

The co-developers of the drug, the nonprofit Global Antibiotic Research & Development Partnership, or GARDP, and Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc., released topline results of the clinical trial on Wednesday.

344

344

PharmaShots

APRIL 28, 2023

Shots: Through this agreement, Vitalli Bio will receive exclusive rights for developing and commercializing DWP213388 in the global market while Daewoong Pharmaceutical will retain rights in some Asian regions incl. Korea In exchange of this right, Vitalli Bio will pay a total of ~$477M incl. an upfront payment of ~$10M.

Biosimilars 40

Biosimilars 40

STAT

MARCH 21, 2024

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. George Yancopoulos is in touch with his teenage self.

305

305

STAT

MAY 7, 2024

At a panel at the Milken Institute 2024 Global Conference Monday, Bastani and other health care leaders addressed the rapidly growing applications of AI in science and health care. Collectively, they acknowledged that developers and health systems have to think critically about AI’s limits to avoid harm to patients.

303

303

pharmaphorum

APRIL 15, 2021

When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront. In the very early phase of development, Astellas also participates in public-private partnerships with academia, regulators, experts and beyond. The impact of COVID-19 and implications for the future.

Labelling 68

Labelling Communication Pharmaceutical Manufacturing Pharmaceutical Companies 68

STAT

OCTOBER 2, 2023

Just two years after the World Health Organization’s historic recommendation of the first malaria vaccine, the global health agency on Monday recommended a second , seeking to broaden access to a tool it hopes can save lives.

Vaccines 312

Vaccines 312

PharmaShots

APRIL 17, 2023

2 P-I trials for PIPE-307 in healthy volunteers have been completed Ref: Businesswire | Image: Janssen Related News:- Janssen Reports P-I Study (CHRYSALIS) Results of Rybrevant (amivantamab-vmjw) for Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

40

40

STAT

OCTOBER 19, 2022

Early in the Covid-19 pandemic, the leaders of wealthy countries pledged to respond with “global solidarity.” When governments of high-income countries belatedly responded to the threat, they sided with pharmaceutical companies that were extracting profits from a global health crisis. Read the rest…

Vaccines 305

Vaccines Pharmaceutical Companies Pharmaceutical Companies 305

Outsourcing Pharma

MARCH 24, 2022

The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders.

59

59

STAT

FEBRUARY 5, 2024

  Under the deal, Novo Holdings is purchasing Catalent, a major contract development and manufacturing company with more than 50 sites globally. LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent in a $16.5

Diabetes 350

Diabetes Pharmaceutical Companies Pharmaceutical Companies 350

STAT

MAY 9, 2024

The work of bringing diversity to research is complex, and several experts gathered at the Milken Institute Global Conference on Wednesday to discuss potential strategies to make progress, starting with ways to build trust among the communities that have a history of being mistreated or exploited by the scientific community.

279

279

STAT

APRIL 10, 2024

Novartis plans to cut up to 680 jobs in its product development organization , Reuters notes. The job eliminations are separate from a restructuring program that could lead to 8,000 of its 78,000 global workforce being cut. Around 440 jobs will go in Switzerland and up to 240 in the U.S. over the next two to three years.

Drug Pricing 221

Drug Pricing 221

STAT

NOVEMBER 3, 2022

The journal Nature published today global consensus recommendations to end Covid-19 as a public health threat. It took a panel of almost 400 independent-thinking scientists, doctors, and representatives of community groups from more than 100 countries (we were among the co-chairs) some 14 months to develop and agree on these recommendations.

346

346

Pharmaceutical Technology

APRIL 24, 2024

Pfizer and its Germany partner BioNTech have urged London’s High Court to invalidate competitor Moderna's patents over technology instrumental in the Covid-19 vaccines development as the latest phase of a global legal fight that started yesterday (23 April), reported Reuters.

Vaccines 130

Vaccines 130

STAT

MARCH 5, 2024

After 18 months of debate, the World Trade Organization failed to adopt a controversial proposal to waive intellectual property protection for Covid-19 diagnostics and treatments, ending a furious attempt by civil society groups to bolster global access to needed medical products. The failure was not a surprise.

Pharmaceutical Manufacturing 302

Pharmaceutical Manufacturing Vaccines 302

STAT

DECEMBER 11, 2023

SAN DIEGO — For decades, the biotech industry has tried — and repeatedly failed — to develop new and effective painkillers without the addictive potential of opioids. Pain is one of the most common and debilitating symptoms and is the leading cause of disability globally.

Diabetes 346

Diabetes Drug Development 346

STAT

MARCH 8, 2024

Since I first began exploring this question more than a decade ago, mental illness has become a global epidemic. Despite significant efforts, progress in psychiatric drug development has remained disappointingly slow. But the landscape remains predominantly marked by failures and a dry drug development pipeline.

Drug Development 250

Drug Development 250

Express Pharma

MAY 10, 2024

In the expansive landscape of global healthcare, India has emerged as a pivotal player, shaping the accessibility and affordability of essential medicines worldwide. The country accounts for 20 per cent of the world’s generic drugs and 60 per cent of the global vaccine supply.

Vaccines 86

Vaccines Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 86

STAT

NOVEMBER 18, 2022

This time around, we note that Daiichi Sankyo hired Mark Rutstein as head, global oncology clinical development. Previously, he worked at Bristol Myers Squibb as vice president, oncology development. Before that, Rutstein was vice president, global oncology clinical development at Bayer Healthcare.

Drug Development 203

Drug Development 203

Outsourcing Pharma

APRIL 29, 2024

OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI regulation for pharmaceuticals, clinical trials, and drug development at a global scale.

Drug Development 86

Drug Development 86

Outsourcing Pharma

MAY 7, 2024

PCI Pharma Services, a global leader in contract development and manufacturing, has embarked on the installation of crucial equipment for its latest sterile fill-finish facility at its Bedford, NH campus in Philadelphia.

82

82

Express Pharma

APRIL 16, 2024

In the expansive landscape of global healthcare, India has emerged as a pivotal player, shaping the accessibility and affordability of essential medicines worldwide. The country accounts for 20 per cent of the world’s generic drugs and 60 per cent of the global vaccine supply.

Vaccines 103

Vaccines Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 103

PharmaShots

APRIL 20, 2023

and in several global markets, including Japan and the European Union. Owens is the Global Brand Development Leader, Insulins, Glucagon & Devices at Eli Lilly & Company. Related Post: Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Japan and Saudi Arabia.

Diabetes 40

Diabetes Labelling 40

European Pharmaceutical Review

MARCH 5, 2024

BeiGene has appointed Pilar de la Rocha as its new Head of Europe, Global Clinical Operations. The biotech’s new appointment underlines its commitment to advancing clinical development initiatives in the European region. Pilar de la Rocha’s career journey to date Pilar de la Rocha as Head of Europe, Global Clinical Operations, Beigene.

Medical Schools 89

Medical Schools 89

Express Pharma

MAY 8, 2024

Merak Ventures, a sector-agnostic early-stage, B2B venture capital (VC) firm, has announced a new investment in Atomgrid, an R&D-first platform for contract development, manufacturing, and sourcing of Specialty Chemicals. Atomgrid is co-founded by IIT-BHU alumni Lakshit Bansal, Siddharth Gupta, and Pratik Chowdhury.

95

95

Express Pharma

APRIL 4, 2024

The companies will join forces to advance the use of precision medicine on a global scale SOPHiA GENETICS, a cloud-native software company in the healthcare space has announced a strategic partnership with Strand Life Sciences to deliver innovative solutions that will fuel the use of precision medicine globally. Jurgi Camblong, PhD.,

100

100

Express Pharma

JANUARY 23, 2024

The Serum Institute of India (SII), is joining a CEPI network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future public health disease outbreaks. With CEPI’s funding, SII will also support the development, stockpiling and licensure of new vaccines against CEPI’s priority pathogens.

Vaccines 96

Vaccines 96

PharmaVoice

JUNE 23, 2023

Monika Vnuk, SVP of global partnering and business development, is setting her sights on out-of-the-box partnerships.

130

130

PharmaTech

MAY 12, 2024

In this podcast, hear from our global experts Martin Gonzalez, PHD and Katharine Sparhawk as they share exclusive details of Pfizer CentreOne’s sterile injectable capabilities from both a technical expertise and business development point of view.

52

52

European Pharmaceutical Review

MAY 14, 2024

Takeda and AC Immune SA have agreed a global option and license agreement for a potential first-in-class Abeta-targeting active immunotherapy for Alzheimer’s. The post Takeda agrees to develop active immunotherapy for Alzheimer’s appeared first on European Pharmaceutical Review.

Immunity 59

Immunity Immunization Drug Development 59

PharmaShots

JUNE 27, 2023

Image Source: Canva About the Author: Dr. Mourad Farouk Rezk is the Head of Global Medical and Development Biogen Biosimilars. Related Post: Monica Mann, VP, of Medical Affairs for Global MS and Pipeline at Biogen Shares Insights on New Data on MS Therapies and Digital Health Research

Biosimilars 40

Biosimilars Diabetes Immunity Immunization 40

World Pharma News

MARCH 15, 2024

Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development.

Hospitals 109

Hospitals 109

European Pharmaceutical Review

MAY 1, 2024

A new state-of-the-art research and laboratory building is being built on AbbVie’s main campus at its Rhineland-Palatinate site, the company ’s second largest research and development ( R&D ) location globally. The new R&D building in Germany is expected to completed in 2027.

Pharmaceutical Manufacturing 87

Pharmaceutical Manufacturing 87

Express Pharma

DECEMBER 15, 2023

The new $16M [USD] workspace will employ 300+ for roles that were formerly outsourced to various outside service providers and will transform into an India-based global hub designed to in-source talent, accelerate technology adoption, and drive technological innovation.

Vaccines 98

Vaccines 98

Outsourcing Pharma

APRIL 29, 2024

OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI regulation for pharmaceuticals, clinical trials, and drug development at a global scale.

Drug Development 52

Drug Development 52

Express Pharma

FEBRUARY 26, 2024

The site will expand the company’s global drug development and IT & digital capabilities Bristol Myers Squibb has announced the official opening of a new facility in Hyderabad. The site will expand the company’s global drug development and IT & digital capabilities and is expected to be home to over 1,500 employees.

Drug Development 97

Drug Development 97